BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference

Rhea-AI Summary

BullFrog AI Holdings (NASDAQ: BFRG), a technology-enabled drug development company leveraging AI and machine learning for pharmaceutical development, has announced its participation in BTIG's Annual Virtual Biotechnology Conference.

CEO Vin Singh will engage in a fireside chat on Wednesday, July 30, 2025, at 11:20 a.m. ET. The company will also be available for one-on-one meetings during the two-day conference, scheduled for July 29-30, 2025.

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Vin Singh, CEO, will participate in a fireside chat and one-on-one meetings at BTIG’s Annual Virtual Biotechnology Conference, being held Tuesday, July 29 through Wednesday, July 30.

Fireside Presentation Details

Date: Wednesday, July 30, 2025

Time: 11:20 a.m. ET

To request access to the presentation, contact: USCorporateAccess@btig.com. Registered attendees can request one-on-one meetings with BullFrog AI management via your BTIG banking representative.

If you are unable to attend the conference and would like to schedule a meeting with BullFrog AI management, please contact BFRG@redchip.com.

About BullFrog AI

BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials.

For more information visit BullFrog AI at: https://bullfrogai.com

Safe Harbor Statement

This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "could," "will," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; our and our partners’ ability to market and sell our offerings and services, including BullFrog Data Networks™ and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Contact:

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
BFRG@redchip.com

FAQ

When is BullFrog AI (BFRG) presenting at the BTIG Biotechnology Conference 2025?

BullFrog AI will present in a fireside chat on Wednesday, July 30, 2025, at 11:20 a.m. ET.

How can investors access BullFrog AI's BTIG conference presentation?

Investors can request access to the presentation by contacting USCorporateAccess@btig.com. Registered attendees can request one-on-one meetings through their BTIG banking representative.

Who will represent BullFrog AI at the BTIG Biotechnology Conference?

Vin Singh, the CEO of BullFrog AI, will represent the company at the conference.

What does BullFrog AI (BFRG) specialize in?

BullFrog AI is a technology-enabled drug development company that uses artificial intelligence and machine learning to facilitate the successful development of pharmaceuticals and biologics.